Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-01

FDA Approved: METHENAMINE HIPPURATE — Supplemental Application (Esjay Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application for methenamine hippurate submitted by Esjay Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methenamine Hippurate (Methenamine hippurate)

Snippet

SUPPL AP for METHENAMINE HIPPURATE (METHENAMINE HIPPURATE)